These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7132761)

  • 1. Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13,14-dihydro-11 beta, 16 xi-cyclo-PGE2.
    Granström E; Fitzpatrick FA; Kindahl H
    Methods Enzymol; 1982; 86():306-20. PubMed ID: 7132761
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13,14-dihydro-11 beta, 16-cyclo-PGE2.
    Granström E; Kindahl H
    Adv Prostaglandin Thromboxane Res; 1980; 6():181-2. PubMed ID: 7386255
    [No Abstract]   [Full Text] [Related]  

  • 3. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
    Bothwell W; Verburg M; Wynalda M; Daniels EG; Fitzpatrick FA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):229-35. PubMed ID: 6948952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability.
    Granström E; Hamberg M; Hansson G; Kindahl H
    Prostaglandins; 1980 Jun; 19(6):933-57. PubMed ID: 7384561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder.
    Mathé AA; Eberhard G; Sääf J; Wetterberg L
    Biol Psychiatry; 1986 Sep; 21(11):1024-30. PubMed ID: 3741918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The measurement of 13,14-dihydro-15-keto prostaglandin E2 by combined gas chromatography mass spectrometry.
    Kelly RW; Abel MH
    Biomed Mass Spectrom; 1983 Apr; 10(4):276-9. PubMed ID: 6850076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability of 13,14-dihydro-15 keto-PGE2.
    Fitzpatrick FA; Aguirre R; Pike JE; Lincoln FH
    Prostaglandins; 1980 Jun; 19(6):917-31. PubMed ID: 7384560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal plasma prostaglandin E2 metabolite levels during human pregnancy and parturition.
    Brennecke SP; Castle BM; Demers LM; Turnbull AC
    Br J Obstet Gynaecol; 1985 Apr; 92(4):345-9. PubMed ID: 3857076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against dehydration products of 15-keto-13,14-dihydro-prostaglandin E2.
    Peskar BM; Günter B; Steffens C; Kröner EE; Peskar BA
    FEBS Lett; 1980 Jun; 115(1):123-6. PubMed ID: 7190101
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects.
    Axelrod L; Shulman GI; Blackshear PJ; Bornstein W; Roussell AM; Aoki TT
    Diabetes; 1986 Sep; 35(9):1004-10. PubMed ID: 3091434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a radioimmunoassay for prostaglandin E2 metabolite levels in plasma.
    Demers LM; Brennecke SP; Mountford LA; Brunt JD; Turnbull AC
    J Clin Endocrinol Metab; 1983 Jul; 57(1):101-6. PubMed ID: 6853670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay for 13,14-dihydro,15-keto-prostaglandin E2 in human plasma: applications and artifacts.
    Metz SA; Rice MG; Robertson RP
    Adv Prostaglandin Thromboxane Res; 1980; 6():183-5. PubMed ID: 7386256
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma.
    Starczewski M; Voigtmann R; Peskar BA; Peskar BM
    Prostaglandins Leukot Med; 1984 Mar; 13(3):249-58. PubMed ID: 6585845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of 13,14-dihydro-15-keto-PGE2 in some biological fluids as measured by radioimmunoassay.
    Levine L
    Prostaglandins; 1977; 14(6):1125-39. PubMed ID: 601248
    [No Abstract]   [Full Text] [Related]  

  • 15. Hapten mimic elicits antibodies recognizing prostaglandin E2.
    Fitzpatrick FA; Bundy GL
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2689-93. PubMed ID: 275836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of 15-Keto-13,14-dihydro-PGE2 in plasma by GC-MS1.
    Hubbard WC
    Methods Enzymol; 1982; 86():571-8. PubMed ID: 7132770
    [No Abstract]   [Full Text] [Related]  

  • 17. An ELISA for PGE2 utilizing monoclonal antibody.
    Neuman RG; Korn JH; Lally ET; Wood DD; Kimball ES
    J Immunoassay; 1988; 9(2):159-77. PubMed ID: 3163699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against prostaglandin E2: binding parameters.
    David F; Somme G; Provost-Wisner A; Theze J; Dray F
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():23-4. PubMed ID: 2936100
    [No Abstract]   [Full Text] [Related]  

  • 19. Myometrial prostaglandins during the human menstrual cycle.
    Vijayakumar R; Walters WA
    Am J Obstet Gynecol; 1981 Oct; 141(3):313-8. PubMed ID: 7306368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human luteal tissue prostaglandins, 17 beta-estradiol, and progesterone in relation to the growth and senescence of the corpus luteum.
    Vijayakumar R; Walters WA
    Fertil Steril; 1983 Mar; 39(3):298-303. PubMed ID: 6572151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.